Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Stomach Neoplasms 1Solid Tumor 1Sezary Syndrome 1Neoplasms 1Mouth Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Kidney Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Advanced/Metastatic Solid Tumors 1Advanced Solid Tumors 1

Interventions

mogamulizumab 1cobomarsen 1Lenalidomide 1Interleukin-15 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia-Lymphoma, Adult T-Cell × mogamulizumab × Clear all
NCT00355472 2012-10-18

Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL

Kyowa Kirin Co., Ltd.

Phase 1 Completed
16 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡